ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

2019 ACR/ARP Annual Meeting

November 8-13, 2019. Atlanta, GA.

View by Number View by Title View Sessions
View by Date
Jump to:  View All • a b c d [e] f g h i j k l m n o p q r s t u v w x y z
  • Abstract Number: 1349
    Earlier Biologic Initiation over Two Decades of Real World Observational Data from the RAPPORT Biologics Registry of Northern Alberta, Canada
  • Abstract Number: 936
    Earlier Treatment of Non-Radiographic Axial Spondyloarthritis with Certolizumab Pegol Results in Improved Clinical and Patient-Reported Outcomes
  • Abstract Number: 140
    Early Anticoagulation Improves the Long-term Prognosis in Patients with Antiphospholipid Syndrome Associated Portal Vein Thrombosis
  • Abstract Number: 2571
    Early Improvement in SLEDAI-2K Responder Index-50 Predicts SRI-4 Response in a Randomized Placebo-Controlled Trial of Ustekinumab (UST) in Systemic Lupus Erythematosus
  • Abstract Number: 387
    Early Mortality in IgG4-Related Disease
  • Abstract Number: 572
    Early Recognition of Patients with Axial Spondyloarthritis by Using a Practical Referral System – Evaluation of the Recently Proposed 2-step Strategy
  • Abstract Number: 177
    Early Retirement Attributed to Rheumatoid Arthritis and Its Predictors in Portugal
  • Abstract Number: 2168
    Early Start of Outpatient Physical Therapy After Knee Replacement Is Associated with More Objectively-measured Steps and Time Spent Upright
  • Abstract Number: 1541
    Early Treatment Failure with Apremilast Among Biologic-naïve Patients with Psoriatic Arthritis
  • Abstract Number: 2361
    Early Treatment of Rheumatoid Arthritis with Disease-Modifying Anti-Rheumatic Drugs at < 3 versus 3-6 Months from Onset of Symptoms: Results from a Cohort of Hispanics from Puerto Rico
  • Abstract Number: 2695
    Early Treatment with Anakinra in Systemic Juvenile Idiopathic Arthritis
  • Abstract Number: 1619
    Early Vascular Ageing as a Predictor of Future Cardiovascular Events and Mortality in Systemic Lupus Erythematosus Patients: A Prospective Cohort Study
  • Abstract Number: 1795
    Education of Rheumatology Faculty: Evaluation of an Interactive Team Based Approach versus Traditional Didactic Teaching
  • Abstract Number: 1192
    Effect of a Clinical Decision Support System on a Quality Indicator of Glucocorticoid-induced Osteoporosis and Trends of Drug Treatment in a Japanese Hospital
  • Abstract Number: 833
    Effect of a Mobile App to Monitor Patient Reported Outcomes in Rheumatoid Arthritis: A Randomized Controlled Trial
  • Abstract Number: 1425
    Effect of ACPA IgM Serostatus on Efficacy Outcomes Following Treatment with Abatacept or Adalimumab: A Post Hoc Analysis of a Phase III Head-to-Head Trial
  • Abstract Number: 2528
    Effect of Additional Administration of HCQ on Pro-inflammatory Cytokine Expression, Especially in Lupus Nephritis
  • Abstract Number: 1636
    Effect of Anti-Topoisomerase I Antibody Status on Decline in Lung Function in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease: Data from the SENSCIS Trial
  • Abstract Number: 1439
    Effect of Baricitinib on Functional Impairment in RA Patients with Moderate Disease Activity and an Inadequate Response to Conventional DMARDs
  • Abstract Number: 2391
    Effect of Biologics on the Hemoglobin A1c in a Population of Rheumatoid Arthritis Patients
  • Abstract Number: 468
    Effect of Body Mass Index on the Disease Activity of Patients with Rheumatoid Arthritis in a Gender Specific Manner and Association of Respective Serum C – Reactive Protein Levels with the Body’s Inflammatory Status
  • Abstract Number: 1876
    Effect of Discontinuation of Denosumab in Subjects with Rheumatoid Arthritis Treated with Glucocorticoids
  • Abstract Number: 76
    Effect of Ifnα and Costimulatory Blockade on Brain Infiltration in a Model of ‘Neuropsychiatric Symptoms of Systemic Lupus Erythematosus’
  • Abstract Number: 2708
    Effect of Immunogenicity on Efficacy and Safety of Subcutaneous or Intravenous Abatacept in Pediatric Patients with Polyarticular-Course JIA: Findings from Two Phase III Trials
  • Abstract Number: 1517
    Effect of Long-Term Treatment with Secukinumab on Cardio-Metabolic Profile in Patients with Active Ankylosing Spondylitis and Psoriatic Arthritis: Pooled 3 Year Analysis
  • Abstract Number: 571
    Effect of Long-term Treatment with TNF-α Inhibitor on Lipid Profile in Spondyloarthritis: Data from Nationwide Korean College of Rheumatology Biologics (KOBIO) Registry
  • Abstract Number: 2459
    Effect of Obesity and Surgical Weight Loss on Joint Surgery Hospitalizations in Psoriatic Arthritis: Data from National Inpatient Sample
  • Abstract Number: 2578
    Effect of Omega-3 Fatty Acids on Systemic Lupus Erythematosus Disease Activity: A Systematic Review and Meta-Analysis
  • Abstract Number: 1483
    Effect of Phosphodiesterase 4 Inhibition with Apremilast on Cardiometabolic Outcomes in Psoriatic Arthritis – Initial Results from the Immune Metabolic Associations in Psoriatic Arthritis (IMAPA) Study
  • Abstract Number: 2275
    Effect of Race and Lupus Nephritis on Pregnancy Outcomes in Systemic Lupus Erythematosus: An Individual Participant Meta-analysis
  • Abstract Number: 1554
    Effect of Secukinumab on Radiographic Progression Through 2 Years in Patients with Active Psoriatic Arthritis: End-of-study Results from a Phase III Study
  • Abstract Number: 338
    Effect of Serum Urate Lowering with Allopurinol on Blood Pressure in Young Adults
  • Abstract Number: 585
    Effect of Testosterone on Spinal Ankylosis in Ankylosing Spondylitis : in Vivo and in Vitro
  • Abstract Number: 875
    Effect of the Dr. Bart Application on Healthcare Use and Clinical Outcomes in People with Osteoarthritis of the Knee And/or Hip in the Netherlands; A Randomized Controlled Trial
  • Abstract Number: 1608
    Effect of the Metabolic Syndrome on Renal Function Decline in Four Rheumatic Diseases: An 8-year Longitudinal Analysis
  • Abstract Number: 1421
    Effect of Tocilizumab on HDL and LDL Characteristics in Patients with Rheumatoid Arthritis: Preliminary Results
  • Abstract Number: 1415
    Effect of Tofacitinib on the Qualitative Profile of High Density Lipoproteins Molecules in Patients with Rheumatoid Arthritis
  • Abstract Number: 2532
    Effect of Treatment on Antiphospholipid Antibodies in SLE
  • Abstract Number: 381
    Effect of Vitamin D Supplementation on Calcium Levels in Patients with Sarcoidosis: A Retrospective Analysis
  • Abstract Number: 1269
    Effective Treatment of TNFα Inhibitors in Chinese Patients with Blau Syndrome
  • Abstract Number: 1546
    Effectiveness and Retention Rate of Secukinumab for Psoriatic Arthritis and Axial Spondyloarthritis: Real-life Data from the Italian LORHEN Registry
  • Abstract Number: 1270
    Effectiveness and Safety of Off-label Use of Tocilizumab in Refractory Autoimmune Diseases: A Multicenter Study
  • Abstract Number: 484
    Effectiveness of Platelet-derived Microparticles for the Diagnosis and Clinical Evaluation of Rheumatoid Arthritis
  • Abstract Number: 276
    Effectiveness of Screening by Nurse with Predetermined Questionnaire on Infections Before Administration of Intravenous Biologics in Patients with Rheumatoid Arthritis
  • Abstract Number: 1500
    Effectiveness of Switching Between TNF Inhibitors in Patients with Axial Spondyloarthritis: Is the Reason to Switch Relevant?
  • Abstract Number: 606
    Effectiveness of TNFi After a First Switch in Patients with Early Axial Spondyloarthritis: A Longitudinal Analysis of the DESIR Cohort
  • Abstract Number: 1063
    Effects of Abatacept on T Regulatory Cells in Early Diffuse Systemic Sclerosis
  • Abstract Number: 1013
    Effects of Anti-TNF on MiR Expression in Monocytes and CD4+ T-Lymphocytes in Spondyloarthritis
  • Abstract Number: 211
    Effects of Deep Haptic Massage in Fibromyalgia (pilot Study)
  • Abstract Number: 2875
    Effects of Filgotinib on Anemia, Thrombocytopenia and Leukopenia: Results from a Phase 3 Study in Patients with Active Rheumatoid Arthritis and Prior Inadequate Response or Intolerance to Biological DMARDs
  • Abstract Number: 1258
    Effects of Intravenous Golimumab, an Anti-TNFα Monoclonal Antibody, on Health-Related Quality of Life in Patients with Ankylosing Spondylitis: 1-Year Results of a Phase III Trial
  • Abstract Number: 1644
    Effects of Nintedanib in Patients with Diffuse and Limited Cutaneous Systemic Sclerosis and Interstitial Lung Disease: Subgroup Analysis of the SENSCIS Trial
  • Abstract Number: 615
    Effects of NSAIDs and TNF Inhibitors on Cardiovascular Events in Ankylosing Spondylitis: A Systematic Review and Meta-Analysis
  • Abstract Number: 1468
    Effects of Resistive Exercise on Fatigue and Disease Activity in Women with Primary Sjogren’s Syndrome
  • Abstract Number: 207
    Effects of Successive Switches to Different Biosimilars Infliximab on Immunogenicity in Chronic Inflammatory Diseases in Daily Clinical Practice
  • Abstract Number: 218
    Effects of Tai Chi versus Aerobic Exercise on Mindfulness in Fibromyalgia
  • Abstract Number: 2620
    Effects of Tofacitinib Suppressed Pulmonary Vascular Remodeling of Allergic Vasculitis in a Murine Model
  • Abstract Number: 1352
    Effects of Upadacitinib on Patient-Reported Outcomes After 24 Weeks in Patients with Active Rheumatoid Arthritis and an Inadequate Response to Conventional Synthetic or Biologic Disease-Modifying Anti-Rheumatic Drugs: Results from SELECT-NEXT and SELECT-BEYOND Phase 3 Studies
  • Abstract Number: 2572
    Efficacy Analysis of Patients with Systemic Lupus Erythematosus Treated with Belimumab or Placebo Plus Standard Therapy in Phase 3 Trials by Baseline Levels of BLyS mRNA and Type 1 Interferon Inducible Gene Signature Status
  • Abstract Number: 363
    Efficacy and Outcomes of Telephone-Based Management Program in Patients with Gout
  • Abstract Number: 548
    Efficacy and Safety of a Novel Subcutaneous Formulation of CT-P13 over the 1-year Treatment Period and After Switching from Intravenous CT-P13 in Patients with Active Rheumatoid Arthritis: Results from Part 2 of Phase I/III Randomized Controlled Trial
  • Abstract Number: 2414
    Efficacy and Safety of Abatacept in Patients with Early Active Primary Sjögren’s Syndrome – Open-label Extension Phase of a Randomized Controlled Phase III Trial
  • Abstract Number: L17
    Efficacy and Safety of Anifrolumab in Patients with Moderate to Severe Systemic Lupus Erythematosus: Results of the Second Phase 3 Randomized Controlled Trial
  • Abstract Number: 2385
    Efficacy and Safety of Chinese Herbal Medicine Biqi Capsule Combined with Methotrexate in Patients with Rheumatoid Arthritis: A Pilot Study
  • Abstract Number: 944
    Efficacy and Safety of Dapirolizumab Pegol in Patients with Moderately to Severely Active Systemic Lupus Erythematosus: A Randomized, Placebo-Controlled Study
  • Abstract Number: 2492
    Efficacy and Safety of Disease-Modifying Drugs in Psoriatic Arthritis (PsA): A Systematic Literature Review
  • Abstract Number: 1092
    Efficacy and Safety of Dose Adjustment Based on Patients’ Body Size in Low Dose Intravenous CYC Treatment for Rheumatic Diseases
  • Abstract Number: 932
    Efficacy and Safety of E6011, an Anti-Fractalkine Monoclonal Antibody, in MTX-IR Patients with Rheumatoid Arthritis
  • Abstract Number: 929
    Efficacy and Safety of Fenebrutinib, a BTK Inhibitor, Compared to Placebo in Rheumatoid Arthritis Patients with Active Disease Despite TNF Inhibitor Treatment: Randomized, Double Blind, Phase 2 Study
  • Abstract Number: 927
    Efficacy and Safety of Filgotinib for Patients with Rheumatoid Arthritis Naïve to Methotrexate Therapy: FINCH3 Primary Outcome Results
  • Abstract Number: 506
    Efficacy and Safety of Filgotinib for Patients with Rheumatoid Arthritis with Inadequate Response to Methotrexate: FINCH1 Primary Outcome Results
  • Abstract Number: 531
    Efficacy and Safety of Gonadotropin-Releasing Hormone Antagonism in Severe Biologic Refractory Rheumatoid Arthritis
  • Abstract Number: 1304
    Efficacy and Safety of Hylan G-F 20 versus Intra-Articular Corticosteroids in Patients with Knee Osteoarthritis: A Systematic Literature Review, Meta-Analysis, and Network Meta-analysis
  • Abstract Number: 2864
    Efficacy and Safety of Intravenous Belimumab in Children with Systemic Lupus Erythematosus: An Across-Trial Comparison with the Adult Belimumab Studies
  • Abstract Number: 2879
    Efficacy and Safety of Low-dose IL-2 in Rebuilting Immunity Re-equilibrium of Psoriatic Arthritis Patients
  • Abstract Number: 1833
    Efficacy and Safety of Nintedanib in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease by Use of Mycophenolate at Baseline: Subgroup Analysis of the SENSCIS Trial
  • Abstract Number: 1643
    Efficacy and Safety of Nintedanib in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease: Subgroup Analysis of the SENSCIS Trial by Corticosteroid Use
  • Abstract Number: 1653
    Efficacy and Safety of Romilkimab in Diffuse Cutaneous Systemic Sclerosis (dcSSc): A Randomized, Double-Blind, Placebo-Controlled, 24-week, Proof of Concept Study
  • Abstract Number: 2730
    Efficacy and Safety of Romosozumab vs Placebo Among Patients with Mild-to-Moderate Chronic Kidney Disease
  • Abstract Number: 2092
    Efficacy and Safety of the Adjuvanted Recombinant Zoster Vaccine in Adults with Pre-existing Potential Immune Mediated Diseases: A Pooled Post-hoc Analysis on Two Parallel Randomized Trials
  • Abstract Number: 2909
    Efficacy and Safety of the Selective Interleukin-1 Receptor Associated Kinase 4 Inhibitor, PF-06650833, in Patients with Active Rheumatoid Arthritis and Inadequate Response to Methotrexate
  • Abstract Number: 1526
    Efficacy and Safety of Tildrakizumab 100 Mg for Plaque Psoriasis in Patients Randomized to Treatment Continuation vs Treatment Withdrawal with Retreatment upon Relapse in a Phase 3 Study
  • Abstract Number: 2667
    Efficacy and Safety of Tocilizumab in Giant Cell Arteritis: A Monocentric Real-life Experience
  • Abstract Number: 2118
    Efficacy and Safety of Tocilizumab Treatment for Anti–human T Lymphotropic Virus Type I Antibody–positive Rheumatoid Arthritis
  • Abstract Number: 1412
    Efficacy and Safety of Tofacitinib Modified-Release 11 Mg Once Daily + MTX in RA Patients with an Inadequate Response to MTX: Open-Label Phase Results from a Global Phase 3b/4 MTX Withdrawal Study
  • Abstract Number: 2728
    Efficacy and Safety of Upadacitinib in a Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 2/3 Clinical Study of Patients with Active Ankylosing Spondylitis
  • Abstract Number: 512
    Efficacy and Safety of Upadacitinib Monotherapy in MTX-naïve Patients with Early Active RA Receiving Treatment Within 3 Months of Diagnosis: A Post-hoc Analysis of the SELECT-EARLY
  • Abstract Number: 520
    Efficacy and Safety Results from a Phase 3 Study of Biosimilar Candidate ABP 710 in Subjects with Moderate to Severe RA
  • Abstract Number: 537
    Efficacy and Safety Results from a Randomized Double-Blind Study That Compared the Proposed Biosimilar ABP 798 with Rituximab in Subjects with Moderate to Severe RA
  • Abstract Number: 2803
    Efficacy of a 3-Month Wearable-enabled Physical Activity Counselling Program for People with Knee Osteoarthritis
  • Abstract Number: 277
    Efficacy of a Counselling Program to Promote Physical Activity in People with Inflammatory Arthritis
  • Abstract Number: 1697
    Efficacy of Apremilast for Oral Ulcers Associated with Active Behçet’s Syndrome over 64 Weeks: Long-term Results from the Japanese Subgroup in a Phase III Study
  • Abstract Number: 860
    Efficacy of Belimumab in Patients of Black Race with Systemic Lupus Erythematosus and High Disease Activity or Renal Manifestations
  • Abstract Number: 519
    Efficacy of Biosimilar Candidate ABP 710 in a Phase 3 Study in Subjects with Moderate to Severe RA: Additional Analysis Focusing on the ACR Individual Components
  • Abstract Number: 1245
    Efficacy of Canakinumab Treatment in Adult-onset Still’s Disease
  • Abstract Number: 206
    Efficacy of Etanercept on Radiographic Progression in Adult Patients with Rheumatoid Arthritis or Psoriatic Arthritis: Final Results from a German Non-Interventional, Prospective, Multi-Center Study
  • Abstract Number: 1704
    Efficacy of Leflunomide for Treatment of Vasculitis
  • Abstract Number: 2344
    Efficacy of Mycophenolate Mofetil in the Treatment of Rheumatoid Arthritis Associated Interstitial Lung Disease
  • Abstract Number: 1408
    Efficacy of Pharmacological Treatment in Rheumatoid Arthritis: A Systematic Literature Review Informing the 2019 Update of the EULAR Recommendations for Management of Rheumatoid Arthritis
  • Abstract Number: 2633
    Efficacy of Remission Induction Regimens in Elderly Patients with ANCA-Associated Glomerulonephritis
  • Abstract Number: 1497
    Efficacy of Secukinumab in a US Patient Population with Psoriatic Arthritis: A Subgroup Analysis of the Phase 3 FUTURE Studies
  • Abstract Number: 1691
    Efficacy of TNF α Inhibitors for Refractory Vascular Behcet’s Disease: A Multicenter Observational Study of 27 Patients
  • Abstract Number: 2682
    Efficacy of Tocilizumab in Giant Cell Arteritis, Independent of the Time of Disease Evolution
  • Abstract Number: 1413
    Efficacy of Tofacitinib Monotherapy, Tofacitinib with Methotrexate and Adalimumab with Methotrexate in Patients with Early ( ≤ 2 Years) vs Established ( > 2 Years) Rheumatoid Arthritis: A Post Hoc Analysis of Data from ORAL Strategy
  • Abstract Number: 310
    Efficacy, Immunogenicity and Cost Analysis of a Systematic Switch from Originator Infliximab to Biossimilar CT-P13 of All Patients with Inflamatory Arthritis from a Single Center
  • Abstract Number: 1402
    Efficacy, Safety and Continuation Rate of Abatacept and Tocilizumab in Patients with Rheumatoid Arthritis : The Comparative Observational Study
  • Abstract Number: L15
    Efficacy, Safety, and Pharmacodynamic Effects of the Bruton’s Tyrosine Kinase Inhibitor, Fenebrutinib (GDC-0853), in Moderate to Severe Systemic Lupus Erythematosus: Results of a Phase 2 Randomized Controlled Trial
  • Abstract Number: 2575
    Electronic Monitoring of Medication Adherence in Young Adults with Childhood-Onset Systemic Lupus Erythematosus over 12 Weeks
  • Abstract Number: 127
    Elevated Levels of the Neutrophil Extracellular Trap-binding Protein LILRA3 in Primary Antiphospholipid Syndrome
  • Abstract Number: 2318
    Elevated Pro-inflammatory Lipid Mediators Associate with Low Paraoxonase 1 Activity in Patients with Rheumatoid Arthritis and Arthritic K/BxN Mice
  • Abstract Number: 125
    Elevated Proliferative Capacity of CD8+ T Cells in Giant Cell Arteritis
  • Abstract Number: 412
    Elevated Serum BAFF Levels in Patients with Dermatomyositis: Association with Interstitial Lung Disease
  • Abstract Number: 640
    Elevated Serum Interleukin-23 Level in Patients with Systemic Lupus Erythematosus Is Associated with Disease Activity, Clinical and Immunological Markers
  • Abstract Number: 2018
    Elevated Serum Levels of Tie-1 in Patients with Rheumatoid Arthritis
  • Abstract Number: 841
    Elevation of Anti-Citrullinated Protein Antibodies Prior to Rheumatoid Arthritis Onset and Risks for Developing Chronic Obstructive Pulmonary Disease or Asthma
  • Abstract Number: 1883
    Elucidating Pain Mechanisms in Polyarticular Juvenile Idiopathic Arthritis Patients
  • Abstract Number: 358
    Emergency Department Encounters in a Large US Payer Database: Tophaceous versus Non-tophaceous Gout Patients
  • Abstract Number: 343
    Emergency Department Length of Stay in Patients with Acute Gout
  • Abstract Number: 221
    Emergency Department Utilization for Fibromyalgia Patients
  • Abstract Number: 2303
    Emotional and Social Determinants of Health Increase Office Communication for Patients with Rheumatoid Arthritis
  • Abstract Number: 1193
    EMR-integrated Disease Activity Calculators Improve Treatment to Target in Rheumatoid Arthritis
  • Abstract Number: 1639
    Endoscopic Findings in a Scleroderma Cohort with and Without Interstitial Lung Disease
  • Abstract Number: 1585
    Endothelial Dysfunction and Arterial Stiffness in Patients with Systemic Lupus Erythematosus: A Systematic Review and Meta-analysis
  • Abstract Number: 57
    Endothelial Progenitor Cells in the Pathophysiology of Interstitial Lung Disease Associated with Rheumatoid Arthritis
  • Abstract Number: 2919
    Endothelial Protein C Receptor and Scavenger Receptor Class B Type 1 Negatively Regulate Vascular Inflammation and Are Major Autoantigens in Takayasu Arteritis
  • Abstract Number: 730
    Energy Levels: An Overlooked Element in Patient Assessment in Scleroderma
  • Abstract Number: 817
    Enhanced Expression of mRNA for TAK1 in CD34+ Cells of the Bone Marrow in Rheumatoid Arthritis
  • Abstract Number: 2032
    Enhanced IFN a Production and STING Pathway in Monocytes in Systemic Lupus Erythematosus Is Suppressed by the Inhibition of mTOR Activation
  • Abstract Number: 2401
    Enhanced Methotrexate Polyglutamation in Japanese as Compared to Caucasian Rheumatoid Arthritis Patients Starting Methotrexate
  • Abstract Number: 594
    Enhanced Performance of the ASAS Classification Criteria by Deletion of Non-Discriminatory Clinical Items: Data from the Screening in Axial Spondyloarthritis in Psoriasis, Iritis, and Colitis Cohort
  • Abstract Number: 154
    Enhancing Medicine Trainees’ Exposure to Gout Diagnosis and Management Through an Interprofessional Approach in the Primary Care Setting
  • Abstract Number: 2130
    Enrichment of IL-17-producing CD4+ T Cells in Synovial Fluid from Patients with Arthritis After anti-CTLA-4 and anti-PD-1 Combination Therapy
  • Abstract Number: 1223
    Enteral Administration of ALLN-346, a Recombinant Urate-degrading Enzyme, Decreases Serum Urate in a Pig Model of Hyperuricemia
  • Abstract Number: 1778
    Entheseal CD90+ SOX9+ Cartilage-like Cells Initiate Spinal Ankylosis in Ankylosing Spondylitis
  • Abstract Number: 2478
    Enthesitis Frequency and Treatment Patterns in Patients with Psoriatic Arthritis in Europe and Japan
  • Abstract Number: 2445
    Enthesitis, Dactylitis, and Axial Disease in Psoriatic Arthritis (PsA): Impact on Patient Quality of Life and Work Productivity
  • Abstract Number: 695
    Environmental and Atmospheric Factors in Systemic Lupus Erythematosus: A Regression Analysis
  • Abstract Number: 1098
    Epidemiology and Mortality of SLE (Systemic Lupus Erythematosus) in Hungary Based on a Nationwide Retrospective Claims Database Study
  • Abstract Number: 908
    Epidemiology and Presentation of Sarcoidosis with and Without HIV Infection
  • Abstract Number: 2054
    Epidemiology of Gout in South Korea with the National Health Insurance Corporation Database
  • Abstract Number: 187
    Epidemiology of JIA-Associated Uveitis: Environmental Factors and Disease Characteristics of a JIA-Associated Uveitis Cohort
  • Abstract Number: 2349
    Epidemiology, Risk/Prognostic Factors, and Treatment Landscape in Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Systematic Literature Review
  • Abstract Number: 1267
    Epidemology, Clinical Features and Relationship to Biological Therapy of Uveitis in Axial Spondyloarthritis: Single Center University Study
  • Abstract Number: 1074
    Epigenetic Regulation-Mediated Reduction in the Expression of Prostacyclin Receptor and Prostacyclin Synthase in Scleroderma Skin, Vascular Smooth Muscle Cells, and Microvascular Endothelial Cells
  • Abstract Number: 2041
    Epigenome-wide Association Study Reveals Differential DNA Methylation in Systemic Lupus Erythematosus Patients with a History of Ischemic Heart Disease
  • Abstract Number: 1029
    Epstein-Barr Virus Interleukin 10 in SLE Pathogenesis
  • Abstract Number: 1163
    Erosions Are the Most Often Reported Structural Lesion on MRI of the Sacroiliac Joints in axSpA Patients with IBP
  • Abstract Number: 2179
    Erosive Hand Osteoarthritis, Metabolic Syndrome and Knee Osteoarthritis: A Cross-sectional Study Using Data from the PROCOAC Cohort
  • Abstract Number: 1654
    Esophageal Dilation and Other Clinical Factors Associated with Pulmonary Function Decline in Patients with Systemic Sclerosis
  • Abstract Number: 1988
    Establishing an in Vitro Model of Hand Osteoarthritis by Generating Induced Pluripotent Stem Cells (iPSc) That Carry Single Nucleotide Polymorphisms Associated with Hand Osteoarthritis Risk
  • Abstract Number: 1102
    Estimate of Prevalence of Secondary Distal Renal Tubular Acidosis Among Patients with Sjogren’s Syndrome and Systemic Lupus Erythematosus in a US Population with Employer-Sponsored Health Insurance
  • Abstract Number: 1953
    Estimating the Infiltration of Immune Cells in Synovium of Rheumatoid Arthritis Compared to Osteoarthritis and Healthy Control Using Transcriptomic Profiling
  • Abstract Number: 553
    Etanercept Biosimilar GP 2015 (Erelzi®) in Rheumatic Diseases: Interim Analysis of Real-World Data from COMPACT: A Multicentric, Prospective, Observational Cohort Study
  • Abstract Number: 1742
    Ethnicity and Neonatal Lupus Erythematosus Manifestations Risk in a Large Multi-Ethnic Cohort
  • Abstract Number: 501
    EULAR Definition of “Arthralgia Suspicious for Progression to Rheumatoid Arthritis” in a Cohort of Patients Included in a Program for Rapid Diagnosis: Role of Ultrasound and Antibodies
  • Abstract Number: 1094
    EULAR Points to Consider for the Development, Evaluation and Implementation of Mobile Health Applications for Self-management in Patients with Rheumatic and Musculoskeletal Diseases
  • Abstract Number: 170
    Evaluating an Illustrated Storybook for Children with Juvenile Idiopathic Arthritis
  • Abstract Number: 225
    Evaluating Fibromyalgia Symptoms in Transgender Patients
  • Abstract Number: 2242
    Evaluating Important Change in Cutaneous Disease Activity as an Efficacy Measure for Clinical Trials in Dermatomyositis
  • Abstract Number: 1732
    Evaluating the New 2018 ACR/EULAR SLE Classification in Pediatric Patients
  • Abstract Number: 1855
    Evaluating the OMERACT Definitions of Ultrasound Gout Structural Lesions in the Diagnosis of Gout
  • Abstract Number: 288
    Evaluating the Performance of a Single-site Musculoskeletal Ultrasound Clinic Associated with an Academic Rheumatology Practice: Diagnostic and Therapeutic Impact on Patient Care and Survey of Patient and Physician Satisfaction
  • Abstract Number: 160
    Evaluation of ACGME Competencies in a Rheumatology Observed Structured Clinical Examination
  • Abstract Number: 1466
    Evaluation of Changes in Oral Health-Related Quality of Life over Time in Patients with Sjögren’s Syndrome
  • Abstract Number: 2486
    Evaluation of Clinical and Functional Parameters by Joint Involvement and Remission in Psoriatic Arthritis
  • Abstract Number: 1399
    Evaluation of Effectiveness and Usage Patterns of Tofacitinib in Treatment of Rheumatoid Arthritis in Australia: An Analysis from the OPAL-QUMI Real World Dataset
  • Abstract Number: 2213
    Evaluation of Factors Associated with Bone Structure in an SLE Cohort Measured by Clinical 3T MRI and DEXA
  • Abstract Number: 2262
    Evaluation of Illness Perception in Systemic Sclerosis Patients with Pulmonary Involvement
  • Abstract Number: 2094
    Evaluation of Influenza and Pneumococcal Vaccination Rate in Patients with Rheumatoid Arthritis and Spondyloarthritis, and the Attitudes of Rheumatologists About Vaccination
  • Abstract Number: 1322
    Evaluation of Intra-articular CNTX-4975 in Subjects with Painful Bilateral Knee Osteoarthritis: Effects on Pain with Walking and Patient Impression of Change in Pain
  • Abstract Number: 879
    Evaluation of Marijuana and Cannabidiol Use in the Rheumatologic Population from a Patient and Clinician Perspective: A Survey-Based Study
  • Abstract Number: 2064
    Evaluation of Methods to Account for Differential Follow-up When Comparing Clinical Trial Data to Observational Data
  • Abstract Number: 354
    Evaluation of Opioid Analgesia in Hospitalized Patients with Acute Crystal Induced Arthritis
  • Abstract Number: 2415
    Evaluation of Pharmacokinetics and Immunogenicity Following Subcutaneous Administration of Abatacept in Primary Sjogren ’s Syndrome (pSS) and RA Patients
  • Abstract Number: 59
    Evaluation of Potential Mechanisms Underlying the Safety Observations of Filgotinib in Clinical Studies in RA
  • Abstract Number: 249
    Evaluation of Real-World Early-Line Abatacept versus Tumor Necrosis Factor Inhibitors Persistence in Rheumatoid Arthritis Patients with Anti-Citrullinated Protein Antibody or Rheumatoid Factor Positivity
  • Abstract Number: 2249
    Evaluation of Rheumatoid Arthritis Patients’ Preferences Using Discrete Choice Experiment
  • Abstract Number: 1670
    Evaluation of Subclinical Coronary Atherosclerosis in ANCA-associated Small Vessel Vasculitides (AAVs) Compared to Matched Controls Through Visual Assessment of Coronary Arterial Calcium (CAC) Score Using Non-Gated Chest Computed Tomography (CT)
  • Abstract Number: 623
    Evaluation of the Early Cervical Structural Changes in Patients with Non-Radiographic Axial Spondyloarthropathy
  • Abstract Number: 866
    Evaluation of the Highly Selective Endothelin a Receptor Antagonist Zibotentan in Systemic Sclerosis Associated Chronic Kidney Disease
  • Abstract Number: 681
    Evaluation of the Lupus Foundation of America – Rapid Evaluation of Activity in Lupus (LFA-REAL) Clinician Reported Outcome (ClinRO) and Patient Reported Outcome (PRO) in a Primarily Mestizo Population
  • Abstract Number: 2898
    Evaluation of the Transcriptome of Non-Lesional, Non-Sun Exposed Skin in Patients with Lupus Nephritis
  • Abstract Number: 1015
    Evidence for Substantial Immune Activation in Asymptomatic ANA Positive Individuals
  • Abstract Number: 1171
    Evidence of Subclinical Joint Inflammation of Hands by Magnetic Resonance Imaging in Patients with Psoriatic Arthritis in Minimal Disease Activity – Interim Analysis
  • Abstract Number: 554
    Evidence to Guide Glucocorticoid Tapering Is Lacking in RA
  • Abstract Number: 1632
    Evidence-based Consensus Statements for the Identification and Management of Interstitial Lung Disease in Systemic Sclerosis
  • Abstract Number: 565
    Evidence-Based Recommendations for the Management of Enteropathic Arthritis: A Rheumatology – Gastroenterology Collaborative Initiative
  • Abstract Number: 2466
    Evolution of Health-Related Quality of Life in Psoriatic Arthritis Patients
  • Abstract Number: 486
    Evolution of Seropositive Arthralgia over Time: Predictors of Evolution to Rheumatoid Arthritis
  • Abstract Number: 2606
    Evolution of Systemic Sclerosis-Related Interstitial Lung Disease After Autologous Hematopoietic Stem Cell Transplantation
  • Abstract Number: 1148
    Examining Five Year Lupus Retention in Care in an Academic Cohort
  • Abstract Number: 1035
    Examining the Transcriptional Impact of Liganded ERα in the Inflammatory Milieu of Systemic Lupus Erythematosus
  • Abstract Number: 329
    Excessive Alcohol Intake Is Associated with Tophi Formation in Gout Patients
  • Abstract Number: 1745
    Exercise Improves Arterial Inflammation in Childhood-onset Takayasu Arteritis: A Randomized Controlled Trial
  • Abstract Number: 275
    Exercise Is Medicine® in Primary Care Practice: Provider Characteristics and Physical Activity Counseling for Patients with Arthritis, DocStyles, 2018
  • Abstract Number: 1031
    Expanded Circulating Peripheral Helper T Cells Are Associated with B Cell Differentiation in Systemic Lupus Erythematosus
  • Abstract Number: 107
    Expanded Peripheral T Helper Cells Characterize the Early Rheumatoid Arthritis Synovium
  • Abstract Number: 1110
    Expanding Access to Research Using Tele-Health: Lupus and Informatics Feasibility Study
  • Abstract Number: 2156
    Expanding the Phenotypic and Genotypic Spectrum in Yao Syndrome
  • Abstract Number: 607
    Expansion of Peripheral Cytotoxic T Cells in Co-morbid Inflammatory Bowel Disease and Spondyloarthritis
  • Abstract Number: 375
    Experience with Biologic Agents for the Treatment of Cardiac Sarcoidosis in a U.S. Academic Medical Center
  • Abstract Number: 1770
    Experimental Rheumatoid Joint Ameliorated by CRISPR Interference Targeting Long Non-coding RNA H19 Through Wnt Signaling Inactivation
  • Abstract Number: 535
    Exploratory Analysis of a Phase 2b Study Confirms Substantial Pain Improvement with Anti-GM-CSF Monoclonal Antibody Otilimab (GSK3196165) in Patients (Pts) with Active RA
  • Abstract Number: 2850
    Exploring Heterogeneity in Rheumatoid Arthritis: Outcomes up to 4 Years of Follow-Up in Patient Clusters Identified by Data-driven Analysis of the BRASS Registry
  • Abstract Number: 183
    Exploring Heterogeneity in Rheumatoid Arthritis: Patient Profiling Through Principal Component and Cluster Analysis of the BRASS Registry
  • Abstract Number: 2797
    Exploring Possible Predictors of Physical Activity in Knee Replacement Patients
  • Abstract Number: 2339
    Exposure to Avian and Fungal Antigens in Patients with Rheumatoid Arthritis-AssociatedInterstitial Lung Disease: Something to Keep in Mind
  • Abstract Number: 1492
    Exposure-Response Analyses for Upadacitinib Efficacy and Safety in Ankylosing Spondylitis – Analyses of the SELECT-AXIS I Study
  • Abstract Number: 1556
    Exposure–Response Modeling of an Oral, Selective Tyrosine Kinase 2 (TYK2) Inhibitor, BMS-986165, for Pain Visual Analog Scale Score, in Patients with Psoriasis and Musculoskeletal Symptoms
  • Abstract Number: 2016
    Expression of Peptidyl-arginine Deiminases in Peripheral Blood Neutrophils and Its Association with Single Nucleotide Variants in Patients with Rheumatoid Arthritis
  • Abstract Number: 2044
    Expression of SLAMF6 and Its Functional Significance in Podocytes of Lupus Nephritis: Report with Consideration Based on the Results of Microarray Analysis in Podocytes of MRL/lpr Mice
  • Abstract Number: 1405
    Expression of Uncoupling Protein-1 in Subcutaneous Fat Is Increased by Tocilizumab
  • Abstract Number: 815
    Expression Profiling of Genes in Rheumatoid Fibroblast‑like Synoviocytes Regulated by Fas Ligand Using cDNA Microarray Analysis
  • Abstract Number: 1874
    Extensive Modeling-Based Bone Formation After 2 Months of Romosozumab Treatment: Results from the FRAME Clinical Trial
  • Abstract Number: 2134
    Extracellular Adenosine Increases IL-6 Production by Aging Tenocytes and May Contribute to the Age-related Pattern of Polymyalgia Rheumatica
  • Abstract Number: 2431
    Extracellular Vesicles in Primary Sjögren’s Syndrome: A Promising Source for Novel Proteomic Biomarkers
  • Abstract Number: 750
    Extravascular Inflammatory Manifestations of Takayasu Arteritis in a Monocentric Cohort
Jump to:  View All • a b c d [e] f g h i j k l m n o p q r s t u v w x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences